HighTower Trust’s AstraZeneca AZN Stock Holding History

HighTower Trust’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$4.42M	Buy	34,445 +28,150	+447%	+$3.79M	0.43%	42
2022 Q4	$851K	Buy	6,295 +1,829	+41%	+$229K	0.08%	117
2022 Q3	$490K	Buy	+4,466	New	+$567K	0.05%	143

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

HighTower Trust's AZN Position: Q1 2023 in Review

HighTower Trust increased its AstraZeneca (AZN) stake by 447% in Q1 2023, buying an estimated $3.79M and bringing the position to 34,445 shares worth $4.42M. The position accounts for 0.43% of the portfolio, ranked #42.

HighTower Trust first reported a position in AZN in Q3 2022 and has held it in 3 quarters since. 1,056 funds tracked by Wall St. Rank hold AZN as of Q1 2023.

HighTower Trust held 34,445 shares of AstraZeneca worth $4.42M as of Q1 2023.
HighTower Trust bought 28,150 AstraZeneca shares in Q1 2023, an estimated $3.79M.
AstraZeneca made up 0.43% of HighTower Trust's portfolio in Q1 2023, its #42 holding.
HighTower Trust first reported a position in AstraZeneca in Q3 2022 and has held it in 3 quarters since.
1,056 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2023.

Based on HighTower Trust's 13F filing for Q1 2023, filed 21 Apr 2023.